• Tagomics

  Participated · Equity · Feb 2024

  Tagomics develops a multiomic platform that integrates genomics, epigenomics and fragmentomics to discover disease markers and improve diagnosis. The platform applies advanced data analysis and machine learning to detect mutations, study epigenetic switches and analyze DNA fragmentation patterns in blood. Tagomics aims to support drug development and therapy selection by enabling strategic partnerships and marker discovery. The company plans to use the new funding to accelerate scientific research and product development, with the goal of delivering simpler and more accurate diagnostics and treatments for cancer and other diseases. Tagomics was launched in July 2020 as a spin-out from the University of Birmingham and is led by CEO Dr. Jack Kennefick. It is based in Cambridge, UK.

• NuVision

  Led · Equity · Mar 2023

  NuVision Biotherapies develops and manufactures amniotic-membrane–based solutions for ophthalmology. Its dual-patented Tereo Process enables scalable processing of amniotic membrane, forming the basis of its product line. The company’s first product, Omnigen, is used in operating theatres, while OmniLenz, a specialised contact lens, delivers the same therapy without surgery, extending treatment to opticians’ practices and outpatient clinics. NuVision now supplies more than 160 NHS centres and private clinics in the UK, including Moorfields Eye Hospital, and serves customers in 12 countries across Europe, Scandinavia and the Middle East. Founded by Dr. Andy Hopkinson, the company is focused on expanding operations and further product development. The newly secured capital will finance this expansion as NuVision seeks broader international reach and additional clinical applications for its technology.

• GivePenny

  Led · Equity · May 2022

  GivePenny provides a digital fundraising platform that lets charities create linked, data-driven donation experiences. The platform allows users to share data and base donations on metrics such as miles covered, milestones achieved, or songs added to playlists. It can connect fundraising experiences to apps including Strava, Twitch, Fitbit, YouTube and Spotify. Features for charities, fundraisers and donors are designed to boost engagement and increase donations. GivePenny is used by organisations such as Mind, Cancer Research UK and Help for Heroes. The company plans to use the new funding to further enhance the platform and enable more charities, big and small, to continue their work; the company is led by CEO Lee Clark.

• Sigmavision

  Led · Equity · Dec 2018

  Sigmavision develops tyre-safety inspection tools centered on the TreadReader handheld scanner, which uses 3D scanning to measure tread depth and tyre wear. The scanner is usable on cars, heavy goods vehicles, buses and trailers and removes errors associated with manual dip gauges. The company also produces drive-over ramps that incorporate the same scanning technology. Founded in 2003 and led by Managing Director Dr Andrew Pryce, Sigmavision initially supplied a major garage equipment engineering firm before launching the TreadReader range to the wider market. The product has attracted interest from tyre manufacturers, garage equipment suppliers and road safety organisations. After securing £1m in funding, the company plans to scale production capacity, set up a global sales and aftersales department, and accelerate product development.

No current team members are available.